Jagsonpal Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹49.78Cr |
Net Profits | ₹3.96Cr |
Net Profit Margins | 7.96% |
Highlights
Revenue:
Jagsonpal Pharmaceuticals Ltd’s revenue fell -19.55% since last year same period to ₹49.78Cr in the Q3 2023-2024. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -17.17% fall in its revenue since last 3-months.
Net Profits:
Jagsonpal Pharmaceuticals Ltd’s net profit fell -49.17% since last year same period to ₹3.96Cr in the Q3 2023-2024. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -46.99% fall in its net profits since last 3-months.
Net Profit Margins:
Jagsonpal Pharmaceuticals Ltd’s net profit margin fell -36.81% since last year same period to 7.96% in the Q3 2023-2024. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -36% fall in its net profit margins since last 3-months.
